Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
description Rank Gene Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1051 to 1100 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fos-related antigen 1 (fra-1). [source:swissprot;acc:p15407]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
46\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.642\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
161.068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.27053\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.641\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
161.046\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.2707\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fragile x mental retardation 1 protein (protein fmr-1) (fmrp). [source:swissprot;acc:q06787]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1828\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.115\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01147\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 1. [source:swissprot;acc:p51114]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1825\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
202.386\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
200.086\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0115\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 2. [source:swissprot;acc:p51116]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1823\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
frg1 protein (fshd region gene 1 protein). [source:swissprot;acc:q14331]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2745\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
201.476\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.514\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00019\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase (ec 3.1.3.11) (d-fructose-1,6-bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:p09467]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2561\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.825\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00169\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2551\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.766\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.148\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00182\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-bisphosphate aldolase a (ec 4.1.2.13) (muscle-type aldolase) (lung cancer antigen ny-lu-1). [source:swissprot;acc:p04075]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2907\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-bisphosphate aldolase b (ec 4.1.2.13) (liver-type aldolase). [source:swissprot;acc:p05062]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2973\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-bisphosphate aldolase c (ec 4.1.2.13) (brain-type aldolase). [source:swissprot;acc:p09972]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3087\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ftsj homolog 3; likely ortholog of mouse ectoplacental cone, invasive trophoblast giant cells, extraembryonic ectoderm and chorion sequence 3. [source:refseq;acc:nm\_017647]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
726\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
244.495\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
232.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05196\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fumarate hydratase, mitochondrial precursor (ec 4.2.1.2) (fumarase). [source:swissprot;acc:p07954]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
731\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.874\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.708\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05187\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fuse binding protein 3 (fragment). [source:sptrembl;acc:q92946]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2668\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.176\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.944\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00107\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fuse-binding protein-interacting repressor isoform b; siah binding protein 1; pyrimidine tract binding splicing factor; ro ribonucleoprotein-binding protein 1; poly-u binding splicing factor puf60. [source:refseq;acc:nm\_014281]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1864\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
203.071\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01086\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fused toes homolog; likely ortholog of mouse fused toes. [source:refseq;acc:nm\_022476]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2124\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.248\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.788\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00696\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fyve-finger-containing rab5 effector protein rabenosyn-5. [source:refseq;acc:nm\_022340]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2998\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fzr1 protein; fizzy-related protein; cdc20-like 1b. [source:refseq;acc:nm\_016263]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
848\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
147.211\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
153.371\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04184\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g protein-coupled receptor 66. [source:refseq;acc:nm\_006056]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2815\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g-rich sequence factor-1 (grsf-1). [source:swissprot;acc:q12849]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1855\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.891\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.542\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0109\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g1 to s phase transition protein 1 homolog (gtp-binding protein gst1-hs). [source:swissprot;acc:p15170]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1631\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.789\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.533\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01511\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b1. [source:swissprot;acc:p14635]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1582\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.098\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.844\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01634\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b2. [source:swissprot;acc:o95067]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1580\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
168.018\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
170.769\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01637\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ga binding protein alpha chain (gabp-alpha subunit) (transcription factor e4tf1-60) (nuclear respiratory factor-2 subunit alpha). [source:swissprot;acc:q06546]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
883\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
227.596\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.017\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03917\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ga binding protein beta-2 chain (gabp-beta-2 subunit) (transcription factor e4tf1-47) (gapbp-2) (nuclear respiratory factor-2 subunit gamma). [source:swissprot;acc:q06545]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
884\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gaba(a) receptor-associated protein; gaba(a)-receptor-associated protein. [source:refseq;acc:nm\_007278]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
48\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
65.4586\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
83.0461\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26868\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
168\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
82.5916\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
98.0548\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18722\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
galactose-1-phosphate uridylyltransferase (ec 2.7.7.12) (gal-1-p uridylyltransferase) (udp-glucose--hexose-1-phosphate uridylyltransferase). [source:swissprot;acc:p07902]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1337\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.162\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.412\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02257\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
galectin-4 (lactose-binding lectin 4) (l-36 lactose binding protein) (l36lbp) (antigen ny-co-27). [source:swissprot;acc:p56470]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2158\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.401\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.796\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00676\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
galectin-9 (hom-hd-21) (ecalectin). [source:swissprot;acc:o00182]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2122\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.473\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.911\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00696\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma adducin (adducin-like protein 70). [source:swissprot;acc:q9uey8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1934\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.264\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.055\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00995\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (neural enolase) (nse) (enolase 2). [source:swissprot;acc:p09104]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2360\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
207.186\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.046\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00415\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p14867]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
628\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
214.256\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
202.14\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p47869]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
621\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p34903]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
629\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-4 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p48169]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
625\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-6 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q16445]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
622\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor epsilon subunit precursor (gaba(a) receptor). [source:swissprot;acc:p78334]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
626\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q8n1c3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
620\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p18507]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
623\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q99928]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
618\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-butyrobetaine,2-oxoglutarate dioxygenase (ec 1.14.11.1) (gamma-butyrobetaine hydroxylase) (gamma-bbh). [source:swissprot;acc:o75936]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1842\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.455\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.113\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01115\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-interferon inducible lysosomal thiol reductase precursor (gamma-interferon-inducible protein ip-30). [source:swissprot;acc:p13284]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3101\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-sarcoglycan (gamma-sg) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q13326]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1181\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.186\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.672\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02593\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-snap-associated factor 1; rab11-interacting protein. [source:refseq;acc:nm\_015470]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1817\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.462\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.926\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01164\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-soluble nsf attachment protein (snap-gamma) (n-ethylmaleimide- sensitive factor attachment protein, gamma). [source:swissprot;acc:q99747]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
166\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
209.299\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
249.187\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19058\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1-like 1. [source:refseq;acc:nm\_024034]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1139\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.484\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.675\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02731\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1. [source:refseq;acc:nm\_018972]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1141\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gastricsin precursor (ec 3.4.23.3) (pepsinogen c). [source:swissprot;acc:p20142]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2470\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
235.812\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.088\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00308\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
47\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
325.586\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
256.492\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26938\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/